文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

脓毒症危重患者的红细胞输注实践

RBC Transfusion Practices in Critically Ill Patients With Sepsis.
PubMed 文献 · Crit Care Med · 2025-10-15
一句话结论脓毒症早期复苏中45.3%患者接受红细胞输注,血红蛋白≥10 g/dL时输注与死亡率升高相关,低于此阈值则呈死亡率下降趋势。

该研究为韩国脓毒症联盟前瞻性多中心观察队列的二次分析,纳入2019年9月至2022年12月13个ICU中2613例成人脓毒症患者,按ICU第1-3天是否接受红细胞输注分为输注组与非输注组。45.3%患者在早期复苏阶段接受红细胞输注,输注当日平均最低血红蛋白为8.8±1.7 g/dL。倾向评分匹配后两组60天死亡率无总体差异,但按ICU第1天血红蛋白10 g/dL阈值分层时存在显著定性交互作用(交互P=0.0124):血红蛋白≥10 g/dL时输注与死亡率升高相关,低于该阈值时呈死亡率下降趋势。作者认为输血决策可依据生理标志物直至9-10 g/dL,但血红蛋白超过10 g/dL时应避免输注。

要点

  • 脓毒症危重患者早期复苏中红细胞输注常见,45.3%在ICU第1-3天接受输注,与指南推荐存在差距。
  • 输注当日平均最低血红蛋白为8.8±1.7 g/dL。
  • 倾向评分匹配后两组60天死亡率无总体差异。
  • 按ICU第1天血红蛋白10 g/dL分层存在显著定性交互作用(交互P=0.0124):≥10 g/dL时输注与死亡率升高相关,低于该阈值时呈死亡率下降趋势。
  • 作者认为输血决策可依据生理标志物直至9-10 g/dL,但血红蛋白超过10 g/dL时应避免输注。

适用人群与场景

  • 19岁及以上成人脓毒症患者,入住ICU后按ICU第1-3天是否接受红细胞输注分为输注组与非输注组。

研究设计与关键结果

  • 研究类型:前瞻性多中心观察队列(韩国脓毒症联盟队列)的二次分析,2019年9月至2022年12月,13个ICU,纳入2613例成人脓毒症患者,平均年龄71.9±13.3岁。
  • 45.3%患者在早期复苏阶段(ICU第1-3天)接受红细胞输注,输注当日平均最低血红蛋白为8.8±1.7 g/dL。
  • 红细胞输注与血红蛋白水平之外的临床因素相关,包括较高的简化急性生理评分3和脓毒症诱导凝血病评分、脓毒性休克、手术源控制、乳酸和胆红素升高、血小板计数低、使用两种或以上血管升压药以及连续性肾脏替代治疗。
  • 倾向评分匹配队列中,两组60天死亡率无总体差异;按ICU第1天血红蛋白10 g/dL阈值分层时观察到显著定性交互作用(交互P=0.0124):血红蛋白≥10 g/dL时红细胞输注与死亡率升高相关,低于该阈值时呈死亡率下降趋势。

证据类型、等级与局限

  • 证据类型:前瞻性多中心观察队列的二次分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为输血决策可依据生理标志物直至9-10 g/dL,但血红蛋白超过10 g/dL时应避免输注,因存在潜在危害。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To assess real-world RBC transfusion practices during early resuscitation in sepsis and evaluate their association with 60-day mortality.

DESIGN: Secondary analysis of a prospective, multicenter observational cohort (the Korean Sepsis Alliance cohort) from September 2019 to December 2022.

SETTING: Thirteen ICUs across South Korea.

PATIENTS: Adults (19 yr old or older) admitted to the ICU with sepsis were categorized into transfused and non-transfused groups based on whether they received RBC transfusions during ICU days 1-3.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Among 2613 patients (mean age 71.9 ± 13.3 yr old), 45.3% received RBC transfusions during the early resuscitation phase. The mean lowest hemoglobin level on the day of transfusion was 8.8 ± 1.7 g/dL. RBC transfusion was associated with clinical factors beyond hemoglobin levels, including higher Simplified Acute Physiology Score 3 and Sepsis-Induced Coagulopathy scores, septic shock, surgical source control, elevated lactate and bilirubin levels, low platelet counts, the use of two or more vasopressors, and continuous renal replacement therapy. In the propensity score-matched cohort, there was no overall difference in 60-day mortality between groups. However, a significant qualitative interaction was observed when stratifying by an ICU day 1 hemoglobin threshold of 10 g/dL ( p for interaction = 0.0124). RBC transfusion was linked to higher mortality at hemoglobin greater than or equal to 10 g/dL, but showed a trend toward decreased mortality below this threshold.

CONCLUSIONS: RBC transfusions are common in critically ill patients with sepsis, highlighting a gap between clinical practice and guideline recommendations. Although not associated with overall mortality, a qualitative interaction was observed at a hemoglobin threshold of 10 g/dL. Transfusion decisions may be guided by physiologic markers up to 9-10 g/dL, but should be avoided when hemoglobin levels exceed 10 g/dL due to the potential for harm.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Song MJ, Seo WI, Jang Y, et al. RBC Transfusion Practices in Critically Ill Patients With Sepsis. Crit Care Med. 2025. PMID: 41090988. doi:10.1097/CCM.0000000000006892

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。